Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by Cdninvstron May 02, 2010 5:28pm
433 Views
Post# 17054236

RE: Consider this...

RE: Consider this...June 16th press release on Nuvo website says that Covidien has U.S. rights to market Penssaid, doesn't say anything about Canada or Greece for that matter. Nothing to do with Paladin....Canadian distributor. Unless, like you say, maybe Paladin will exit the scene and Covidien will take over North American distribution. Cheers Skier59. Perhaps this is the beginning of the slippery slope whereby Covidien assimilates everything around Nuvo before ultimately taking over Nuvo.......like a giant macrophage.
Bullboard Posts